NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
2018 · Alzheimer s & Dementia · 9,924 citations
https://doi.org/10.1016/j.jalz.2018.02.018
S
Samantha Budd Haeberlein
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
75
Papers
13.4K
Citations
20
h-index
26
i10-index
Samantha Budd Haeberlein is an academic researcher from Biogen (United States). The author has contributed to research in topics: Alzheimer's disease research and treatments & Dementia and Cognitive Impairment Research & Cholinesterase and Neurodegenerative Diseases. The author has an h-index of 20, co-authored 64 publications.
ORCID: 0000-0002-4824-646XPapers by this author
worksTwo Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease
2022 · The Journal of Prevention of Alzheimer s Disease · 1,228 citations
https://doi.org/10.14283/jpad.2022.30
AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer’s Disease
2016 · Journal of Alzheimer s Disease · 86 citations
https://doi.org/10.3233/jad-160701
TANGO: a placebo-controlled randomized phase 2 study of efficacy and safety of the anti-tau monoclonal antibody gosuranemab in early Alzheimer’s disease
2023 · Nature Aging · 70 citations
https://doi.org/10.1038/s43587-023-00523-w
Investigating Partially Discordant Results in Phase 3 Studies of Aducanumab
2023 · The Journal of Prevention of Alzheimer s Disease · 22 citations
https://doi.org/10.14283/jpad.2023.6
Clinical Meaningfulness in Alzheimer's Disease Clinical Trials. A Report from the EU-US CTAD Task Force
2024 · The Journal of Prevention of Alzheimer s Disease · 16 citations
https://doi.org/10.14283/jpad.2024.112
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat